1068 related articles for article (PubMed ID: 29627570)
1. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
[TBL] [Abstract][Full Text] [Related]
2. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
Liu G; Guo W; Rao M; Qin J; Hu F; Li K
Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
Li X; Shen M
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
[TBL] [Abstract][Full Text] [Related]
4. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC.
Li MF; Li YH; He YH; Wang Q; Zhang Y; Li XF; Meng XM; Huang C; Li J
Biomed Pharmacother; 2018 Mar; 99():848-858. PubMed ID: 29710484
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
[TBL] [Abstract][Full Text] [Related]
8. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
[TBL] [Abstract][Full Text] [Related]
10. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p.
Pu J; Wang J; Li W; Lu Y; Wu X; Long X; Luo C; Wei H
J Cell Mol Med; 2024 Mar; 28(6):e15010. PubMed ID: 32077624
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of circ_HIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p/DLX2 axis.
Zhang H; Dai Q; Zheng L; Yuan X; Pan S; Deng J
Biochem Biophys Res Commun; 2020 Dec; 533(3):501-509. PubMed ID: 32977948
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
13. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0016788 regulates hepatocellular carcinoma progression via miR-506-3p/poly-adenosine diphosphate-ribose polymerase.
Chen M; Hu G; Zhou X; Peng Z; Wen W
J Gastroenterol Hepatol; 2021 Dec; 36(12):3457-3468. PubMed ID: 34340259
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
Cao S; Wang G; Wang J; Li C; Zhang L
Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
[TBL] [Abstract][Full Text] [Related]
17. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
[TBL] [Abstract][Full Text] [Related]
20. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
